California Public Employees Retirement System’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-64,100
Closed -$1.52M 2189
2021
Q1
$1.52M Sell
64,100
-6,260
-9% -$162K ﹤0.01% 2210
2020
Q4
$938K Sell
70,360
-490
-0.7% -$4.71K ﹤0.01% 2521
2020
Q3
$491K Buy
70,850
+7,200
+11% +$71.8K ﹤0.01% 2773
2020
Q2
$782K Buy
+63,650
New +$359K ﹤0.01% 2397

Other funds holding IBRX

California Public Employees Retirement System's IBRX Position: Q2 2021 in Review

California Public Employees Retirement System sold out of ImmunityBio (IBRX) in Q2 2021, closing a stake of 64,100 shares — an estimated $1.52M sold.

California Public Employees Retirement System first reported a position in IBRX in Q2 2020 and held it in 4 quarters. The position peaked at $1.52M in Q1 2021. 125 funds tracked by Wall St. Rank hold IBRX as of Q2 2021.

  • California Public Employees Retirement System reported no remaining ImmunityBio position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 64,100 ImmunityBio shares in Q2 2021, an estimated $1.52M.
  • California Public Employees Retirement System first reported a position in ImmunityBio in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's ImmunityBio position peaked at $1.52M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.